Column Capital Advisors’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Column Capital Advisors’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$2.72K	Hold	100	–	–	﹤0.01%	663
2023 Q2	$3.15K	Hold	100	–	–	﹤0.01%	671
2023 Q1	$2.72K	Buy	+100	New	+$3.02K	﹤0.01%	696
2022 Q2	–	Sell	-112	Closed	-$4K	–	738
2022 Q1	$4K	Buy	+112	New	+$3.88K	﹤0.01%	603

Other funds holding SBIO

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

SFS

Strategic Financial Services Utica, New York $2.28B AUM 22.9% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

NAM

NTV Asset Management Charleston, West Virginia $1.02B AUM 31.16% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Column Capital Advisors's SBIO Position: Q3 2023 in Review

Column Capital Advisors held its ALPS Medical Breakthroughs ETF (SBIO) position steady in Q3 2023 at 100 shares worth $2.72K. The position accounts for ﹤0.01% of the portfolio, ranked #663.

Column Capital Advisors first reported a position in SBIO in Q1 2022 and has held it in 4 quarters since. The position peaked at $4K in Q1 2022. 37 funds tracked by Wall St. Rank hold SBIO as of Q3 2023.

Column Capital Advisors held 100 shares of ALPS Medical Breakthroughs ETF worth $2.72K as of Q3 2023.
Column Capital Advisors left its ALPS Medical Breakthroughs ETF share count unchanged in Q3 2023.
ALPS Medical Breakthroughs ETF made up ﹤0.01% of Column Capital Advisors's portfolio in Q3 2023, its #663 holding.
Column Capital Advisors first reported a position in ALPS Medical Breakthroughs ETF in Q1 2022 and has held it in 4 quarters since.
Column Capital Advisors's ALPS Medical Breakthroughs ETF position peaked at $4K in Q1 2022.
37 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q3 2023.

Based on Column Capital Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.